Tirzepatide: Dual GIP/GLP-1 Receptor Agonism and Clinical Trials
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in large pharmaceutical clinical programmes. Evidence for the regulated medicine does not validate the identity, sterility or performance of catalogue research material.Biological context and mechanismBoth incretin pathways influence glucose-dependent insulin…